Gilenya, the first oral MS treatment, approved in Europe
Gilenya, the first oral MS treatment, approved in Europe
The European Commission has granted Novartis approval for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosis (RRMS) despite treatment with beta interferon, or in patients with rapidly evolving severe RRMS.
"Today marks an important step forward in the way we manage this chronic, debilitating disease in Europe,” said Professor Hans-Peter Hartung, Professor and Chairman, Dept. of Neurology, Heinrich-Heine University, Germany. “Gilenya is the first approved therapy for MS that offers significant efficacy in a capsule, which for many patients will come as a welcome additional option.”... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1071 Views
-
Last post by frodo
-
- 1 Replies
- 1147 Views
-
Last post by Petr75
-
- 0 Replies
- 171 Views
-
Last post by NHE
-
- 5 Replies
- 14899 Views
-
Last post by gibbledygook
-
- 5 Replies
- 2515 Views
-
Last post by Jaded
-
- 0 Replies
- 4607 Views
-
Last post by NHE
-
- 0 Replies
- 2608 Views
-
Last post by Cece
-
- 0 Replies
- 2778 Views
-
Last post by NHE
-
- 0 Replies
- 2253 Views
-
Last post by frodo